MET and esophageal squamous cell carcinoma: A c-Met inhibitor, BPI-9016 M, exerts radiosensitization of ESCC cells by reducing phosphorylation of ATR and ATM, upregulating apoptosis-related molecules and inhibiting homologous recombination (HR) [74].